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ABSTRACT Received wisdom in the ﬁeld of fungal biology holds that the process of editing a genome by
transformation and homologous recombination is inherently mutagenic. However, that belief is based on
circumstantial evidence. We provide the ﬁrst direct measurement of the effects of transformation on a fungal
genome by sequencing the genomes of 29 transformants and 30 untransformed controls with high coverage.
Contrary to the received wisdom, our results show that transformation of DNA segments ﬂanked by long
targeting sequences, followed by homologous recombination and selection for a drug marker, is extremely
safe. If a transformation deletes a gene, that may create selective pressure for a few compensatory mutations,
but even when we deleted a gene, we found fewer than two point mutations per deletion strain, on average.
We also tested these strains for changes in gene expression and found only a few genes that were consistently
differentially expressed between the wild type and strains modiﬁed by genomic insertion of a drug resistance
marker. As part of our report, we provide the assembled genome sequence of the commonly used laboratory










One of the fundamental techniques of molecular biology is editing
a genome by integrating a DNA molecule at a speciﬁc site. The goal
may be to introduce a new sequence, eliminate an existing sequence, or
both. This technique is widely used on both a gene-by-gene scale and a
genome-wide scale. The ﬁrst comprehensive, targeted gene knockout
collection was made by replacing 96% of open reading frames in the
genome of Saccharomyces cerevisiae with a drug resistance cassette
(Winzeler et al. 1999; Giaever et al. 2002; Giaever and Nislow 2014).
Since then, deletion collections have beenmade for Schizosaccharomyces
pombe (Kim et al. 2010; Spirek et al. 2010) and Neurospora crassa
(Dunlap et al. 2007; Roche et al. 2014), and a collection forCryptococcus
neoformans var. grubii is currently under construction. In these organ-
isms, the ﬁrst step in genome editing is transformation with linear DNA
containing a selectable drug resistancemarker and targeting sequences on
both ends, which are homologous to the ﬂanking regions of the genome
sequence to be replaced. Homologous recombination swaps the exoge-
nous DNA for the target DNA, enabling the recombinant cells to survive
selection on a drug that is lethal to cells lacking the resistance marker.
Despite the widespread use of transformation, it has long been
thought that this process may lead to unwanted, collateral mutations
that confound studies of the intended mutations (Shortle et al. 1984;
Giaever et al. 2002; Johnston et al. 2002; Scherens and Goffeau 2004).
However, the evidence cited in support this claim is circumstantial (see
Discussion). The worry about transformation being mutagenic has
been even greater among researchers making targeted deletions in
C. neoformans, an opportunistic, pathogenic fungus that is estimated to
cause several hundred thousand deaths per year (Rajasingham et al.
2017). Transformation of this yeast, which is surrounded by a thick
cell wall and a polysaccharide capsule (Srikanta et al. 2014), requires
biolistic DNA delivery. In this process, DNA-coated gold beads are
ﬁred at the cells at high velocity, penetrating both the capsule and the
cell wall (Armaleo et al. 1990). The violence of biolistic transformation
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has led to concerns that it may physically damage chromosomes, lead-
ing to abnormal karyotypes.
It is important to distinguish between (a) collateral damage from the
transformation process itself and (b) mutations that arise after trans-
formation and are selected for because they compensate for a reduction
inﬁtness due to deletion of a gene. There is evidence to support the latter
(see Discussion), but the former has never been studied directly.
In this paper, we present the ﬁrst analysis and characterization of the
collateral mutations from genetic transformation—and any potential
impact on gene expression—using C. neoformans var. grubii, strain
KN99a (haploid cells). We carried out 23 independent biolistic trans-
formations on Cryptococcus, in each of which a drug marker was
inserted in an apparently neutral site (J. Lodge, personal communica-
tion) on chromosome 11 (Figure 1, left). We characterized these trans-
formants for virulence-related phenotypes that are frequently studied
in Cryptococcus, carried out RNA sequencing (RNA-seq) on a subset of
transformants to identify potential effects on gene expression, and
sequenced the 23 genomes to high coverage. As a control for preexisting
variation in the freezer stock, we also sequenced 30 nontransformed
cultures, each inoculated by selecting single colonies after streaking out
of the same freezer vial (Figure 1, right). For comparison, we also
sequenced the genomes of six strains in which the same drug markers
had been used to delete genes (Figure 1, center).
The reference genome sequence for C. neoformans var. grubii was
obtained from laboratory strain H99a (Loftus et al. 2005; Janbon et al.
2014). Since then, another laboratory strain, KN99a (Nielsen et al.
2003), has become increasingly popular, because it is nearly congenic
to H99a but exists in both mating types and is competent tomate. As a
fringe beneﬁt of our study of transformation, we obtained the genome
sequence of strain KN99a, which has not been previously published.
We have deposited that sequence, along with annotations transferred
from H99a, in public databases, and we provide a brief description of
the differences between the KN99a and H99a genomes.
MATERIALS AND METHODS
Cell growth, transformation, and phenotypic assays
Unless indicated otherwise, cells were grown on yeast peptone dextrose
(YPD) at 30, with shaking (230 rpm) for liquid cultures. Biolistic
transformation was performed as previously described (Toffaletti et al.
1993) for genomic integration of marker cassettes (“neutral transfor-
mations”) and for gene deletion [as in Maier et al. (2015)]. For pheno-
typic assays, 5 aliquots of 10-fold serial dilutions were spotted and
incubated at 30 or 37 onmedium containing various stressors. (Details
of these and other procedures are provided in Supplemental Material,
Supplemental Methods in File S2.)
RNA-seq and gene expression analysis
Strain growth, RNA isolation, and RNA-seq library preparation were
performed as in Gish et al. (2016) in biological triplicate, and libraries
were sequenced on an Illumina HiSeq 2500. Genes were analyzed for
differential expression using DESeq 1.24.0 (Anders and Huber 2010); a
gene was considered consistently differentially expressed in a strain if
its adjusted P-value was ,0.01 in all triplicate sets and its expression
level changed by two-fold or greater in at least one of the triplicate sets
compared with the control.
Genome sequencing
Genomic DNA was isolated and libraries prepared as detailed in the
Supplemental Methods in File S2, with sequencing on an Illumina
HiSeq 2500 to obtain paired-end 101 bp reads.
Genome read alignment
Genome sequencing reads were aligned to the reference genome se-
quenceusingbothBowtie2.2.5 (LangmeadandSalzberg2012)andBWA-
MEM 0.7.12 (Li 2013) with default parameters. PCR duplicates were
removed using the rmdup command from SAMtools 1.3 (Li et al. 2009).
Copy number variant calling
Copynumbervariants(CNVs)werecalledwithCNVnator0.3.2 (Abyzov
et al. 2011) using default parameters, based on both Bowtie2 and BWA-
MEM alignments. Each CNV is assigned a mean depth of coverage
relative to the genome-wide depth of coverage. CNVs were considered
duplications if the read depth was at least 1.9 times the genome-wide
average for the strain. CNVswere considered deletions if the normalized
depthwas nomore than 0.25 times the genome-wide average. All CNVs
that overlapped with repeats identiﬁed with RepeatMasker 4.0.5 (Smit
et al. 2013) using default parameters were discarded.
Structural variant calling
Reads from BWA-MEM alignments were processed through
SAMBLASTER 0.1.24 (Faust and Hall 2014) to separate discordant
read pairs and split reads from all other reads. The split and discor-
dant reads were input to LUMPY (Layer et al. 2014) with default
parameters to call structural variants.
SNP and indel calling and analysis
After alignment, the nonsplit, concordant read pairs were ﬁlteredwith a
mapping quality threshold of 1 for BWA-MEM and 42 for Bowtie2.
These thresholds eliminate reads that align equally well to multiple
locations in the reference sequence, such as in low complexity and/or
repetitive regions. Next, Freebayes 1.1.0 (Garrison andMarth 2012) was
used with the parameter -p 1 to call single-nucleotide polymorphisms
(SNPs) and indels on Bowtie2 and BWA-MEM alignments. Only high-
quality polymorphisms (P, 10-7) were kept. See Supplemental Meth-
ods in File S2 for additional details.
KN99a reference genome construction
Reads from the 30 nontransformed strains were used to produce the
KN99a genome sequence as described in Figure S1 in File S1. This
sequence is archived as National Center for Biotechnology Information
(NCBI) BioSample SAMN06704791.
Data availability
All genome sequence reads have been deposited in the NCBI Sequence
ReadArchive under accessions SRS2184920, SRS2220286, SRS2220449,
SRS2220125, SRS2220451, SRS2220454, SRS2220455, SRS2220462, and
SRS2220463. The KN99a genome sequences and annotations we used
are archived at NCBI (BioProject accession PRJNA384617, assembly
and annotation accession ASM221672v1, and BioSample accession
SAMN06704791). All RNA-seq data has been deposited in the NCBI
GEO database under accession GSE104198.
RESULTS
Transformation
All transformed strains received cassettes conferring resistance to either
geneticin (G418) (Hua et al. 2000) or nourseothricin (NAT) (McDade
andCox 2001), which included 1000 bp of the sequence 59 and 39 of the
genomic region to be replaced (Figure 1). Cells were transformed using
a split marker approach (Fu et al. 2006; Kim et al. 2009), in which the
cassette is split across two segments of linear DNA that overlap by
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500 bp. Resistance is conferred only when homologous recombination
fuses the two overlapping segments and integrates them into the ge-
nome, replacing everything between the targeted ﬂanking regions. The
linear DNA was coated onto 0.6 mm gold beads and delivered to a
concentrated patch of cryptococcal cells on rich YPD medium using a
Bio-Rad PDS-1000 high-velocity biolistic particle delivery vacuum sys-
tem (Toffaletti et al. 1993). In 23 of the strains, the cassette was targeted
to the same apparently neutral site in the genome (neutral transform-
ants; Figure 1, left). In another six strains, the cassette was targeted to
replace the complete open reading frame of a transcriptional regulator
(Figure 1, center). These strains were selected from among amuch larger
set of regulator deletion strains, because RNA-seq data (Maier et al.
2015) revealed that their drug resistance cassettes (three G418, three
NAT) had unusually high or low expression, suggesting the possibility
of multiple marker integration events or partial marker integration.
After biolistic transformation, the transformed cells were incubated
overnight at 30, transferred to fresh YPD plates containing the appro-
priate drug, and grown for a further 48–72 hr; single colonies were then
restreaked onto the same medium for growth and analysis. PCR- and
sequence-validated strainswere frozen down and used for the remainder
of this study.
Phenotypes
The 23neutrally transformed strainswere tested for growth at 37 in the
presence of high-salt (1.2 M KCl or NaCl), cell wall or membrane
stressors (0.5% Congo red, 0.01% sodium dodecyl sulfate, 0.2% calco-
ﬂuor white, or 6% ethanol), or host-like oxidative or nitrosative stress
inducers (1 mM H2O2 or 0.5 mM NaNO2). They were also tested for
the ability to produce melanin when grown on medium containing
L-DOPA, a characteristic associated with cryptococcal virulence. Fi-
nally, the width of their capsules was measured. No abnormal pheno-
types were observed (data not shown).
Genome sequencing and analysis
Wesequenced thegenomesof the23neutral transformants, six regulator
deletion strains, and 30 nontransformed control strains. To obtain the
control strains, the same freezer vial was sampled 30 times onto in-
dependent YPDplates. After restreaking, a single colonywas grown and
treated in a way that mimicked the transformation process, except that
biolistic transformation was skipped and the drug was omitted from
subsequent growth onYPDplates.We extracted genomicDNA from all
59 strains, prepared Illumina sequencing libraries, and obtained paired-
end 101 bp reads by Illumina sequencing.
Sequencing and assembly of C. neoformans var. grubii
strain KN99a
Thereads fromthe30wild-type control strainswere aligned to theH99a
reference genome sequence and variants were called. Variants that
occurred in all or all-but-one of the nontransformed strains were used
to construct a reference genome sequence for KN99a. Attempts to
assemble the small fraction of reads that could not be mapped to the
H99 reference did not reveal any signiﬁcant KN99 contigs that failed to
map to H99. After completing an iterative alignment and reﬁnement
process (Figure S1 in File S1), the gene annotation from H99a was
transferred to KN99a, with adjustments dictated by the new sequence.
This revealed a 70-bp displaced duplication within a 39 untranslated
region (UTR) and four large deletions. The deletions affect the 59UTRs
of two genes and eliminate SGF29 (CNAG_06392) almost completely
(Table S1 in File S1). The loss of SFG29 in the KN99 lineage was recently
observed by another group, which attributed the relatively high virulence
of KN99 to it (Arras et al. 2017). The other major feature of the KN99a
sequence was a 285 kb region (chromosome 11:175,000–460,000) that
was highly diverged from H99a. Within the diverged region, there were
4301 substitutions (one per 66 bp, vs. one per 153,778 bp in the re-
mainder of the genome) and 369 small insertions or deletions (one per
772 bp, vs. one per 331,836 bp in the remainder of the genome). The
differences from H99a affected 108 of 115 proteins encoded in the vari-
able region. This variable region can be traced to the original creation of
KN99a, in which H99a was crossed with a strain derived from clinical
isolate 8–1 and then backcrossed to H99a 10 times (Nielsen et al. 2003;
Janbon et al. 2014). The 285 kb divergent region matches the sequence
from strain 8-1 and was retained despite the 10 backcrosses to H99a.
Variants in KN99a
To identify variants within our freezer stock of wild-type KN99a, we
aligned the reads from the 30 nontransformed strains to the new
KN99a genome sequence and ﬁltered out dubious variants, as de-
scribed in Supplemental Methods in File S2. At the end of this process,
only seven variant sites remained. Six of these fell in the diverged region
of chromosome 11 (Table S3 in File S1). At four of these sites there was
only a single alternate (i.e., nonreference) allele. At the remaining three
sites all 30 genomes differed fromH99a, but there was variation within
Figure 1 Overview of the study design
and procedures. The KN99a genome as-
sembly was guided by the H99a genome
sequence, as described in Supplemental
Methods in File S2.
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the KN99a freezer population itself (Table S3 in File S1, column “Alt.”).
Notably, in each genome a signiﬁcant fraction of reads supported each
allele at the six variant sites on chromosome 11 (Table 1, column
“MF”), suggesting variation among the cells in each culture. These
appear to be due to genuine ambiguity in the detailed alignments of the
reads, asmost have secondary alignments that are very near to the primary
in genome coordinates and in alignment score. One variant in the 30 non-
transformed strains occurred on a different chromosome, was supported
by 95% of the aligned reads, and occurred in only one strain (Table 1, “30
Nontransformed”). This appears to be a genuine polymorphism.
A limitation of this and all following analyses is that, as expected,
4.15% of the H99 genome was not covered by an average of at least ﬁve
uniquely mapped reads, when averaged across all 30 nontransformed
strains. This includes centromeres and other repetitive DNA. Variants
found in these areas might be missed by our analysis owing to their
repetitive nature.
Side effects of transformation
After removing all of the variants found in the nontransformed control
strains, eight high-conﬁdence variant sites remained in the 23 neutrally
transformed strains. Four of these fell within one of the targeting ﬂanks
of the insertedDNA (Table S2 in File S1, top). These may simply reﬂect
PCR errors that occurred prior to transformation and cannot be con-
sidered side effects of transformation. The other four (Table 1, “23 Neu-
trally Transformed”) appear to be genuine mutations. In three cases, the
alternate allele occurred in only one strain, and the fourth occurred in
only two strains (Table 1, column “AC”). Furthermore, these alternate
alleles were supported by 99–100% of reads (Table 1, column “MF”). In
n Table 1 Variant alleles found in 30 control strains (top), 23 neutrally transformed strains (middle), and six gene deletion strains (bottom)
30 Nontransformed
Chr Pos Reference Alternate AC Strain AO RO MF (%) Gene Effect
4 574814 TAA TAAA 1 WT 54 3 95 05155a Promoter
23 Neutrally Transformed
Chr Pos Reference Alternate AC Strain AO RO MF (%) Gene Effect
2 22453 G(T)11C G(T)12C 1 G418_20 10 0 100 06794b Intron
2 303154 T G 1 NAT_40 29 0 100 STE6c Silent
3 422414 C T 1 NAT_6 48 0 100 LIV10d E508K
14 79613 G C 2 G418_28 36 0 99 CAT2e Promoter
G418_47
Six Gene Deletion Strains
Chr Pos Reference Alternate AC Strain AO RO MF (%) Gene Effect
1 1524172 A C 1 pkr1Δ 49 0 100 00593f Silent
1 2183532 G T 1 yrm103Δ 24 0 100 00823g Silent
2 1492740 A G 1 ssn801Δ 25 0 100 04048h V471A
5 410958 G(A)10T G(A)9T 1 pkr1Δ 33 1 97 01397i 39 UTR
6 91956 A G 1 ssn801Δ 28 1 97 02524 j Silent
6 1082445 C T 1 yrm103Δ 41 2 95 02146k T236I
7 1162733 G A 1 ssn801Δ 21 0 100 05900l S29L
8 531945 G C 1 ccd6Δ 56 0 100 03269m P58R
9 1050856 G C 1 yrm103Δ 31 0 100 VPS4n P110A
14 837564 AG(TCG)4 AG(TCG)5 1 ssn801Δ 13 0 100 05636o 59 UTR
1 1231133 TCA GAG 6 All 6 5 0 98 07362p E68S
7 1278590 ATT ATTT 6 All 6 27 2 91 N/A Intergenic
Chr, chromosome on which the variant occurs; Pos, coordinate of the variant in the KN99a reference genome sequence; Reference, reference allele; Alternate,
alternate allele; AC, “alternate count,” the number of strains with the alternate allele; Strain, the strain or strains in which the alternate allele is found; AO, “alternate
observations,” the mean number of reads supporting the alternate allele in strains with the alternate allele; RO, “reference observations,” the mean number of reads
supporting the reference allele in strains with the alternate allele; MF, “mean fraction,” the mean fraction of reads supporting the alternate allele in strains with the
alternate allele; Gene, the name or KN99 gene identiﬁer (CKF44 number) of the gene affected by the variants; Effect, the effect of the variant on the protein encoded
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three of the four, read depth at the variant sites was typical of the genome-
wide coverage (Table 1, column “AO”). These results suggest that side-
effect mutations may occur, although the frequency of mutations in the
transformants (4 out 23) was not different from their frequency in the
control strains (1 out 30) at a statistical signiﬁcance threshold of 0.05
(Fisher’s exact P , 0.14). Thus, transformation-induced mutations, if
they exist at all, are strikingly rare: we observed an average of only 0.22
mutations per neutrally transformed strain.We also observed one partial
multiple insertion of the drug marker in these strains (Figure 2B).
Side effects of transformation with gene deletion
For the six strains inwhich a genewas deleted, the situationwas different
from both the nontransformed and neutrally transformed strains.
Thirteen variant sites were identiﬁed across these strains. One of these
fellwithin the targetingﬂankof the linearDNAthatwas transformed into
the cells (Table S2 in File S1, bottom row). The other 12 fell in genomic
regions that were apparently unrelated to the region targeted—11 of
them were on different chromosomes from the targeted gene. These
12 had good coverage (Table 1, column “AO”), and nearly 100% of
reads supported the alternate alleles (Table 1, column “MF”). Two of
them occurred in all six gene deletion strains and likely represent drift in
the freezer stock resulting from laboratory passage, as discussed below.
The other 10 occurred in only one strain each (Table 1, column “AC”),
yielding an average of 1.67 mutations per gene deletion strain, notably
higher than the rate in neutrally transformed strains.
We also found evidence for multiple tandem insertions of themarker
in three of the six gene deletion strains and one of the 23 neutrally
transformed strains. The higher frequency in the gene deletion strains is
not surprising—these strains were selected for sequencing because they
expressed the drugmarker at very high or very low levels. These multiple
insertions were initially identiﬁed by the LUMPY software (Layer et al.
2014) on the basis of split reads (Figure 2) and are independently and
strongly supported by read depths that are many times the genome-wide
average. Two of themultiple insertion strains express themarker at a very
high level and one expresses it at a very low level. One possible explana-
tion for the latter is that the marker could have inserted into a poorly
expressed region of the genome, so that only strains with multiple copies
could express it at a high enough level to survive the drug. This hypoth-
esis is supported by the observation that the gene targeted for deletion
had very low expression in our RNA-seq data (Maier et al., 2015) .
Variants ﬁxed by a bottleneck during
laboratory passage
Two point mutations occurred in all six gene deletion strains. These
seemed unlikely to represent rare side effects of transformation or
compensation for loss of a deleted gene, since the six strains carried
deletions of six different genes. We noticed that all six deletion strains
were constructed in July 2010, whereas our KN99a reference sequence
was based on cultures inoculated from cells streaked from a frozen
stock in March 2016. This led us to hypothesize that the “alternate”
alleles were actually the major alleles prior to a bottleneck event that
occurred between these dates, potentially when the freezer stock was
depleted and a new stock was grown from a single colony of the old
stock in late 2011. To investigate the possibility of a bottleneck ﬁxing
random mutations, we called variants in transcribed regions using
RNA-seq reads (Maier et al. 2015). We identiﬁed four other SNPs with
allele frequencies of 5–11% in 84 strains cultured in 2010 and 2011 and
frequencies of 93–100% in 104 strains cultured since January 2012.
Although neither of the two SNPs listed in Table 1 was in an expressed
region, the existence of other SNPs that went rapidly to ﬁxation at the
same time supports the theory that a bottleneck event in late 2011 led to
ﬁxation of the current KN99a sequence, eliminating what was the
major allele at the time in the freezer stock used to construct the six
gene deletion strains.
Gene expression analysis by RNA-seq
To determine whether any mutations induced by transformation af-
fected gene expression, we carried out RNA-seq on three strains that
were neutrally transformedwith theG418drug resistance cassette, three
that were neutrally transformed with the NAT resistance cassette, and
one untransformed wild type, each in biological triplicate. We then
focused on genes that were differentially expressed by at least two-
fold (adjusted P-value ,0.05), leaving us with between one and 13
differentially expressed genes for ﬁve of the strains and one out-
lier strain (NAT_6) with 65. Five genes (CKF44_00549, CKF44_01093,
CKF44_01680, CKF44_02711, CKF44_06402) were differentially
expressed in all three NAT transformants, of which one (CKF44_00549)
was also differentially expressed in all three G418 transformants.
Apart from CKF44_01680, which is homologous to a methylcrotonoyl-
coenzyme A carboxylase, these ﬁve consistently differentially expressed
genes are all hypothetical conserved proteins with no gene ontology
annotations and no known domains. These consistently differentially
expressed genes were not clustered in one region of the genome, and
none was near the marker insertion site. Apart from these, each strain
contained only a few differentially expressed genes, except for NAT_6
(discussed below).
DISCUSSION
After analyzing genomic sequences from 23 strains in which a drug
marker had been inserted in an apparently neutral location and
Figure 2 Evidence from split read alignments
for tandem insertions. The top part of each
panel shows the expected insertion and the
aligned, observed sequence (colored arrows
connected by a dotted line indicate the se-
quence of the read). The bottom part of each
panel explains this observation. (A) Multiple
insertions of the complete marker cassette
with targeting ﬂanks. (B) Partial sequences
lacking the terminator and 39 targeting ﬂank.
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30nontransformed control strains,we found a very low rate of collateral
mutations resulting from the transformation process. All 23 transfor-
mations together resulted in only four point mutations, of which one
changed an amino acid, and one case of multiple tandem insertions
of the drug marker. Furthermore, none of the 23 transformants
showed any abnormal stress resistance phenotypes.
Our ﬁndings stand in striking contrast to the receivedwisdom in the
ﬁeld,which is that transformation is inherentlymutagenic.However, the
only published evidence supporting this belief comes from the con-
struction of the yeast knockout (YKO) collection. The YKO collection
was constructed by transforming a drug marker cassette into diploid
cells, in order to replace one copy of the target gene. The diploids were
then sporulated to produce four haploid spores, two of which carry the
drug resistance cassette. Only 25% of the gene deletions caused slow
growth directly—that is, with 100% linkage to the drug resistance trait.
However, an estimated 6.5% of the transformed diploids contained a
mutation that caused a growth defect that was unlinked to the drug
resistance cassette. These growth defects were assumed to result from
collateral mutations that affect gene function. Since only 25% of such
mutations would be expected to yield growth defects, it was estimated
that the total collateral mutation rate was 6.5% / 25% = 26% of diploids
(Giaever et al. 2002).
There are several possible explanations for the discrepancy between
our sequencing-based ﬁnding and the inference made from the YKO
collection. First, we transformed haploid strains, so any mutants that
displayed slow growth in haploids would be unlikely to be picked after
growth on plates with selectivemedia.However, wewould still expect to
see the remaining three quarters of the collateral mutations (75  26% =
19.5%), which do not affect growth in rich medium, in our genome
sequences. The fact that we did not may result from several differences
in the two transformation protocols. The YKO protocol involves per-
meabilizing cells with lithium acetate, whereas we used biolistic trans-
formation. It has been thought that the biolistic process might damage
chromosomes, but we saw no evidence of structural variants or CNVs
in any of the 29 neutrally transformed strains. It is possible that the
lithium acetate protocol is more mutagenic than biolistic transforma-
tion. Another important difference is that our drug cassette was split
between two linear DNA segments with overlapping sequences to sup-
port homologous recombination between them (“split marker trans-
formation”) (Kim et al. 2009; Fu et al. 2006), making off-target
insertions that yield drug-resistant transformants less likely. Finally,
each of the DNA pieces we used for transformation contained 1000 ba-
ses of targeting homology, whereas the YKO protocol uses only 45–
80 bp of targeting homology on each end. The shorter homologous
segments, combined with the transformation of an intact marker cas-
sette, could lead to more secondary, off-target insertions. Anecdotal
evidence supporting that idea comes from the recollection that, dur-
ing construction of the YKO collection, a signiﬁcant number of drug-
resistant transformants retained the gene targeted for replacement
(L. Riles, personal communication).
Differences between theDNArepairmechanismsof S. cerevisiae and
those of C. neoformans could, in principle, also contribute to a higher
rate of off-target insertions in S. cerevisiae. DNA repair mechanisms
have not been studied in detail in C. neoformans, although it has been
observed thatCryptococcus has a lower homologous recombination rate
than S. cerevisiae (Davidson et al. 2000; Chun and Madhani 2010) and
that this can be mitigated by deleting genes required for nonhomolo-
gous end joining (Goins et al. 2006).
The one amino acid-changing mutation found in the 23 neutrally
transformed strains occurred in LIV10, a homolog of S. cerevisiae RPP1,
which encodes an RNase subunit involved in processing of precursor
rRNA and tRNA as well as nuclear RNA turnover. This may explain
why the strain bearing this mutation (NAT_6) expressed 65 genes at
signiﬁcantly different levels compared with wild-type cells, many more
than the other transformants subjected to RNA-seq. Speciﬁcally, the
differential expression of many of these genes may be due to changes in
RNA maturation or degradation.
It is important to distinguish between mutagenicity of the trans-
formation process, for which we found no evidence, and selection for
naturally occurring variants that compensate for the loss of a targeted
gene. In the six gene-deletion strains we sequenced, we did see a greater
mutation rate than in the neutrally transformed strains. We found an
average of 1.67 collateral point mutations and 0.5 cases of multiple
tandemmarker insertionper transformation.This is substantiallyhigher
than the rate found for neutral transformations, but still low in an
absolute sense. The tandem marker insertions are certainly not repre-
sentative of all gene deletion strains, since these strains were selected
fromamuch larger collectionof deletion strains becauseof their extreme
marker expression in RNA-seq data. Of the collateral mutations, only
four (0.67 per gene deletion strain) affected amino acids and none
occurred in genes with obvious relationships to the deleted gene.
The greater number of variant alleles in gene deletion strains is
consistent with recent evidence for selection of natural variants after
transformation, owing to the loss of a deleted gene (Teng et al. 2013).
After transformation and selection of a clonal colony, yeast cells are
typically grown for 30 generations before they are stored, during
which one would expect107 mutation events (Teng et al. 2013). This
would provide ample variation, some of which might be under positive
selection in the absence of the deleted gene. Teng et al. found that
different individual cells within supposedly homogeneous strains of
the YKO collection had different phenotypes in at least one of two
assays they performed. Of the strains they tested, 72% displayed heri-
table diversity in these phenotypes that was stable over long periods of
time. They concluded that deletion of almost any gene can cause se-
lection for variants that arise naturally during cell culture. These ﬁnd-
ings suggest that we should see variants supported by 20–80% of reads
in at least 70% of our six gene deletion strains.We did not observe such
variants, but six deletion strains is a very small sample. To further
investigate this, we analyzed alignments of 378 RNA-seq expression
proﬁles (including single and double deletions of .50 genes) for var-
iants showing the pattern that would be predicted by the ﬁnding of
Teng et al. that individual YKO strains are phenotypically diverse.
Speciﬁcally, we looked for variants covered by at least 10 reads in a
sample, including at least ﬁve reads supporting the variant, with at least
20% of reads supporting the reference allele and 20% supporting the
variant. We only found eight such variants among the 378 samples
analyzed. Seven of the eight variants occurred in.1 sample, although
they did not occur in multiple samples of the same genotype as would
be expected if they had been selected for by the loss of the deleted gene.
In summary, we did not see the evidence of diversity within cultures
that would be expected based on the ﬁndings of Teng et al.
Our ﬁnding of 1.67 point mutations per gene deletion strain is
broadly consistent with recent sequencing-based studies in S. cerevisiae.
A study of deletion mutants with slow growth phenotypes that showed
large improvements after 400 generations of laboratory passage found
an average of six point mutations and 0.5 small indels per strain
(Szamecz et al. 2014). The slightly larger number is not surprising given
the selection of the strains for initial gene knockouts that were delete-
rious and themuch larger number of generations of laboratory passage.
A study of suppressormutants found an average of eightmutations that
the authors interpreted as being noncompensatory, in addition to the
compensatory mutation (van Leeuwen et al. 2016). Many of these
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mutations were in genes that are known to be frequently mutated after
laboratory passage that ends in nutrient-limited stationary phase, likely
because the mutations delay the slowing of growth in response to nu-
trient limitation (Comyn et al. 2017). Many of the strains sequenced
were selected because they were suspected to have an off-target muta-
tion, and the rest were selected based on a slow growth phenotype linked
to a marker gene. Thus, they were not a random sample of deletion mu-
tants. A third study found one to four private SNPs per strain in six gene
deletion strains and 0.8–1.6 in 10 strains transformed with a barcode-
marker construct that did not delete a gene (Jaffe et al. 2017).
Although widespread aneuploidy in the YKO strains has been
reported (Hughes et al. 2000), we found no evidence for aneuploidy
in our six deletionmutants or 23 neutrally transformed strains.We also
searched for evidence of aneuploidy in our RNA-seq data consisting of
233 wild-type samples, 139 gene deletion samples, and six overexpres-
sion samples. We did not see any sign of aneuploidy on a whole-
chromosome scale, although it is possible that there were duplications
of ,500 kb. One possible explanation for the difference between our
ﬁndings and those of Hughes et al. is based on their observation that, in
yeast, the duplicated region often contained a gene that was highly
homologous to the deleted gene. It could be thatCryptococcus has fewer
such highly homologous gene pairs, since S. cerevisiae underwent a
whole-genome duplication within the last 100 My.
In conclusion, we have found biolistic transformation, using split
markers ﬂanked by 1 kb of targeting homology, to be a safe process with
few unintended consequences. Thus, investigators should feel conﬁdent
in constructing mutant strains by this process and even using it re-
peatedly to effect multiple changes in the same strain. In contrast to the
transformation process itself, gene deletion may select for a few spon-
taneous point mutations. However, such mutations, even when they
change a single amino acid, are much less likely to cause a visible
phenotype than deleting an entire gene, so any observed phenotypes are
likely attributable to the intended deletion; this can be conﬁrmed by
complementation.
We also found that regrowing freezer stocks froma single colony can
cause bottlenecks that ﬁx variants within the freezer population. Each
bottleneck could ﬁx multiple variants, causing increasing divergence
from the reference isolate over multiple bottleneck events. We recom-
mend that investigators keep a single, master population in the freezer
that has undergone as fewpassages from the reference isolate as possible.
Contrary to standard practice, we recommend that when expansion of
this master population is needed, it should be done without selecting a
single colony.
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